Compendia Bio

Ann Arbor, United States Founded: 2006 • Age: 20 yrs Acquired By Life Technologies
Cancer genomics data is collected and analyzed for drug development.
Request Access

About Compendia Bio

Compendia Bio is a company based in Ann Arbor (United States) founded in 2006 was acquired by Life Technologies in October 2012.. Compendia Bio operates in a competitive market with competitors including Human Longevity, DNAnexus, Genomics, Seven Bridges Genomics and Depixus, among others.

  • Headquarter Ann Arbor, United States
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Cloud, Data & Analytics Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.33 M (USD), Grant

    Aug 01, 2010

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Life Technologies

    (Oct 08, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Compendia Bio

  • Total Funding
  • Total Rounds 6
  • Last Round Grant — $1.3M
  • First Round

    (27 Sep 2007)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2010 Amount Grant - Compendia Bio Valuation

investors

HHS
Jul, 2010 Amount Grant - Compendia Bio Valuation

investors

HHS
Sep, 2009 Amount Grant - Compendia Bio Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Compendia Bio

Compendia Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Life Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Tools and technologies for biotech and biopharma research were supplied.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Compendia Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Compendia Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Compendia Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Compendia Bio

Compendia Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, DNAnexus, Genomics, Seven Bridges Genomics and Depixus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomics data and cell therapy-based diagnostic and therapeutic solutions
domain founded_year HQ Location
Cloud-based genome informatics and data management are provided.
domain founded_year HQ Location
Genomic risk assessment and prevention platform is provided.
domain founded_year HQ Location
Cloud-based platform to analyze, store, and act on genomic data.
domain founded_year HQ Location
Single-molecule genetic and epigenetic sequencing solutions are provided.
domain founded_year HQ Location
Genomic data is analyzed and interpreted via web-based applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Compendia Bio

Frequently Asked Questions about Compendia Bio

When was Compendia Bio founded?

Compendia Bio was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Compendia Bio located?

Compendia Bio is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

What does Compendia Bio do?

Compendia Bioscience specializes in collecting, analyzing, and integrating cancer genomics data for drug development, diagnostics and personalized medicine. Data collection process includes direct correspondence with study authors to gather all available sample facts, often beyond those presented in the original publication. Its main products are Oncomine, aggregates and analyze the oncology data and provide practical, actionable views on the data and results. Oncopredictor, a biomarker discovery platform, performs comprehensive analyses to identify genomic biomarkers of in vitro drug response and importantly, predicts patient populations most likely to benefit from the drug, oncology companion diagnostics platform, Oncoscore, leverages the molecular diversity of cancer to provide deep molecular sub-typing of cancer patients. On October 8, 2012 the company was acquired by Life Technologies, which is a part of Thermo Fisher Scientific.

Who are the top competitors of Compendia Bio?

Compendia Bio's top competitors include DNAnexus, Human Longevity and Eagle Genomics.

Who are Compendia Bio's investors?

Compendia Bio has 2 investors. Key investors include HHS, and Life Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available